Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.

The Price/FCF ratio is N/A as of 2026-10-06T20:48:51.206Z.

Stored calculation inputs

Calculation as of: 2026-10-06T20:48:51.206Z.

Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 1,837,354
TTM free cash flow · period ending 2026-06-30: -19,599,000

FMP input reference: 4def03d60821895559c9c20c19e54220183163157c982acdbaf0d7b6ba02223d

P/E Ratio|FCF Growth|Operating Margin|All Metrics

XAIR Price/FCF Ratio Metrics

PRICE/FCF RATIO

N/A

PRICE/FCF RATIO AVG TTM

N/A

PRICE/FCF RATIO AVG 3Y

N/A

PRICE/FCF RATIO AVG 5Y

N/A

PRICE/FCF RATIO AVG 10Y

N/A

PRICE/FCF RATIO AVG 15Y

N/A

PRICE/FCF RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

N/A

CURRENT VS 3Y AVG

N/A

CURRENT VS 5Y AVG

N/A

CURRENT VS 10Y AVG

N/A

CURRENT VS 15Y AVG

N/A

CURRENT VS 20Y AVG

N/A

XAIR Competitors' Price/FCF Ratio

XAIR

Beyond Air, Inc.

Current

Market Cap

$1.84M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

TNON

Tenon Medical, Inc.

vs XAIR

Market Cap

$1.84M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PFSA

Profusa, Inc. Common Stock

vs XAIR

Market Cap

$1.83M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

TCRT

Alaunos Therapeutics, Inc.

vs XAIR

Market Cap

$1.81M

Price/FCF Ratio

N/A

TTM Avg

81.45

3Y Avg

81.45

5Y Avg

81.45

RNAZ

TransCode Therapeutics, Inc.

vs XAIR

Market Cap

$1.88M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

AMIX

Autonomix Medical, Inc.

vs XAIR

Market Cap

$1.88M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SILO

Silo Pharma, Inc.

vs XAIR

Market Cap

$1.64M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GOVX

GeoVax Labs, Inc.

vs XAIR

Market Cap

$2.13M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

VVOS

Vivos Therapeutics, Inc.

vs XAIR

Market Cap

$2.14M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LABT

Lakewood-Amedex Biotherapeutics, Inc.

vs XAIR

Market Cap

$1.52M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	PRICE/FCF RATIO	TTM	3Y	5Y
Beyond Air, Inc. (XAIR)	$1.84M	N/A	N/A	N/A	N/A
Tenon Medical, Inc. (TNON)vs ›	$1.84M	N/A	N/A	N/A	N/A
Profusa, Inc. Common Stock (PFSA)vs ›	$1.83M	N/A	N/A	N/A	N/A
Alaunos Therapeutics, Inc. (TCRT)vs ›	$1.81M	N/A	81.45	81.45	81.45
TransCode Therapeutics, Inc. (RNAZ)vs ›	$1.88M	N/A	N/A	N/A	N/A
Autonomix Medical, Inc. (AMIX)vs ›	$1.88M	N/A	N/A	N/A	N/A
Silo Pharma, Inc. (SILO)vs ›	$1.64M	N/A	N/A	N/A	N/A
GeoVax Labs, Inc. (GOVX)vs ›	$2.13M	N/A	N/A	N/A	N/A
Vivos Therapeutics, Inc. (VVOS)vs ›	$2.14M	N/A	N/A	N/A	N/A
Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs ›	$1.52M	N/A	N/A	N/A	N/A

Price/FCF Ratio Formula & Definition

P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

XAIR Price/FCF Ratio History

DATE	PRICE/FCF RATIO
2019-11-06	77.40
2019-11-05	81.89
2019-11-04	81.66
2019-11-01	83.40
2019-10-31	83.20
2019-10-30	84.66
2019-10-29	86.11
2019-10-28	87.07
2019-10-25	90.94
2019-10-24	85.14
2019-10-23	86.49
2019-10-22	80.69
2019-10-21	86.49
2019-10-18	86.69
2019-10-17	87.07
2019-10-16	86.69
2019-10-15	84.37
2019-10-14	81.50
2019-10-11	86.88
2019-10-10	91.01
2019-10-09	84.57
2019-10-08	85.91
2019-10-07	87.44
2019-10-04	87.44
2019-10-03	88.43
2019-10-02	88.43
2019-10-01	89.78
2019-09-30	89.03
2019-09-27	90.56
2019-09-26	83.59
2019-09-25	80.69
2019-09-24	86.69
2019-09-23	88.43
2019-09-20	95.40
2019-09-19	90.56
2019-09-18	90.94
2019-09-17	93.96
2019-09-16	94.43
2019-09-13	95.59
2019-09-12	95.78
2019-09-11	95.78
2019-09-10	94.81
2019-09-09	95.40
2019-09-06	95.20
2019-09-05	94.81
2019-09-04	96.56
2019-09-03	93.46
2019-08-30	95.78
2019-08-29	95.98
2019-08-28	94.81
2019-08-27	96.56
2019-08-26	96.36
2019-08-23	96.75
2019-08-22	96.17
2019-08-21	95.78
2019-08-20	98.30
2019-08-19	97.33
2019-08-16	99.16
2019-08-15	101.39
2019-08-14	40.87
2019-08-13	40.58
2019-08-12	40.33
2019-08-09	40.58
2019-08-08	39.26
2019-08-07	40.82
2019-08-06	41.27
2019-08-05	39.13
2019-08-02	40.18
2019-08-01	41.08
2019-07-31	40.42
2019-07-30	41.70
2019-07-29	41.78
2019-07-26	42.18
2019-07-25	41.22
2019-07-24	41.38
2019-07-23	42.99
2019-07-22	42.18
2019-07-19	43.15
2019-07-18	43.39
2019-07-17	43.31
2019-07-16	47.25
2019-07-15	45.80
2019-07-12	42.10
2019-07-11	41.14
2019-07-10	42.10
2019-07-09	39.37
2019-07-08	36.96
2019-07-05	44.09
2019-07-03	44.43
2019-07-02	44.43
2019-07-01	44.03
2019-06-28	44.60

Price/FCF Ratio: N/A

XAIR Price/FCF Ratio Chart

XAIR Price/FCF Ratio Metrics

XAIR Competitors' Price/FCF Ratio

Free Cash Flow Valuation

Price/FCF Ratio Formula & Definition

XAIR Price/FCF Ratio History

Related Metrics